Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
February 29, 2024 08:00 ET
|
Phathom Pharmaceuticals
Phathom Pharmaceuticals to host a conference call on Thursday, March 7, 2024, at 8:30 a.m. ET to report Q4 and full year 2023 financial results.
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 29, 2024 07:00 ET
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...
Nicotine Replacement Therapy Market Insights, Competitive Landscape, and Market Forecast to 2030
February 28, 2024 12:18 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Growth Opportunities and Business Models Driving Sustainability in Pharmaceuticals Industry with Focus on Case Studies for Johnson & Johnson, Astra Zeneca, Pfizer, Piramal Pharma Solutions, and Amcor
February 26, 2024 11:16 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities and Business Models Driving Sustainability in Pharmaceuticals Industry" report has been added to ResearchAndMarkets.com's...
Global L-Carnitine Market Size is Estimated to Reach USD 267.60 million by 2030, Growing at a CAGR of 4.7%: Straits Research
February 26, 2024 10:05 ET
|
Straits Research
New York, United States, Feb. 26, 2024 (GLOBE NEWSWIRE) -- L-carnitine is an amino acid that aids in fat metabolism and is used as a supplement in patients with low energy levels. Red meat, salmon,...
Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
February 26, 2024 09:06 ET
|
Pressure BioSciences, Inc.
Uncle Bud's Reports Early Synergies and Measurable Performance Metrics in First Month Since PBIO Acquisition
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
February 26, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...
Pharma E-Commerce Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Amazon, Apotek, CVS Health, L Rowland & Co, Mckesson, Netmeds Marketplace, and Optum
February 26, 2024 04:19 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Pharma E-Commerce Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
February 23, 2024 13:50 ET
|
Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...
Top 5 Growth Opportunities for the Pharmaceutical Industry in 2024
February 23, 2024 04:38 ET
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024" report has been added to ResearchAndMarkets.com's offering. In 2024, the life...